Pfizer plans to submit the new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine.
Pfizer will submit new data to the FDA this week about trials of its vaccine for kids younger than 5 years old. Here, a girl holds her sister's hand as a nurse prepares to administer the COVID-19 vaccine at a vaccination clinic in Los Angeles. Kids 5 and older have been eligible for the vaccine since last November.
Pfizer and its partner, BioNTech, plan to submit the new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine. The third dose was"well tolerated among 1,678 children under 5 years of age with a safety profile similar to placebo," Pfzier said as itKids in the trial received the third shot at least two months after their second dose, the company said, adding that at the time of the vaccine trial, omicron had become the predominant COVID-19variant in the U.S.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ex-Lake Erie Crushers food-beverage director launching bRaised in the CLE food truckExpect apple-and honey-glazed pork braised for eight hours in apple juice with a mix of herb de Provence and light barbecue rub that yields an “incredible” sweetness.
Read more »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in…
Read more »
Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune response, with a safety profile that was similar to placebo, the companies said:
Read more »
Pfizer says 3 COVID shots protect children under 5Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week.
Read more »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
Read more »
Pfizer: 3-Dose COVID Vaccine Is Safe, Effective for Kids Under 5Preliminary data suggested the three-dose series is 80% effective in preventing symptomatic COVID-19 for children younger than 5.
Read more »